These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36605999)

  • 1. Recombinant human bone morphogenetic protein-2 in spine surgery: recommendations for use and alternative bone substitutes-a narrative review.
    Malham GM; Louie PK; Brazenor GA; Mobbs RJ; Walsh WR; Sethi RK
    J Spine Surg; 2022 Dec; 8(4):477-490. PubMed ID: 36605999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
    Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
    Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoinductive bone graft substitutes for lumbar fusion: a systematic review.
    Agarwal R; Williams K; Umscheid CA; Welch WC
    J Neurosurg Spine; 2009 Dec; 11(6):729-40. PubMed ID: 19951027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
    Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
    Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates.
    Schmitt PJ; Kelleher JP; Ailon T; Heller JE; Kasliwal MK; Shaffrey CI; Smith JS
    Neurosurgery; 2016 Aug; 79(2):212-21. PubMed ID: 26702838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review.
    Liu S; Wang Y; Liang Z; Zhou M; Chen C
    Spine (Phila Pa 1976); 2020 Jun; 45(12):E729-E741. PubMed ID: 31923133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein-2 and bone marrow aspirate with allograft as alternatives to autograft in instrumented revision posterolateral lumbar spinal fusion: a minimum two-year follow-up study.
    Taghavi CE; Lee KB; Keorochana G; Tzeng ST; Yoo JH; Wang JC
    Spine (Phila Pa 1976); 2010 May; 35(11):1144-50. PubMed ID: 20139805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study.
    Carreon LY; Glassman SD; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine (Phila Pa 1976); 2009 Feb; 34(3):238-43. PubMed ID: 19179918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
    Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
    Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.
    Kadam A; Millhouse PW; Kepler CK; Radcliff KE; Fehlings MG; Janssen ME; Sasso RC; Benedict JJ; Vaccaro AR
    Int J Spine Surg; 2016; 10():33. PubMed ID: 27909654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
    Carragee EJ; Hurwitz EL; Weiner BK
    Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.
    Im SK; Lee JH; Lee KY; Yoo SJ
    Orthop Surg; 2022 Jul; 14(7):1350-1358. PubMed ID: 35633034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.
    Kaiser MG; Groff MW; Watters WC; Ghogawala Z; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Sharan A; Wang JC; Dhall SS; Resnick DK
    J Neurosurg Spine; 2014 Jul; 21(1):106-32. PubMed ID: 24980593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological substitutes/extenders for spinal arthrodesis: which agents are cost-effective?
    Hsu WK; Hashimoto RE; Berven SH; Nassr A
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S86-98. PubMed ID: 25299264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Computed Tomography Analysis of the Success of Spinal Fusion Using Ultra-Low Dose (0.7 mg per Facet) of Recombinant Human Bone Morphogenetic Protein 2 in Multilevel Adult Degenerative Spinal Deformity Surgery.
    Liu G; Tan JH; Yang C; Ruiz J; Wong HK
    Asian Spine J; 2018 Dec; 12(6):1010-1016. PubMed ID: 30322256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.